drugset / Trial / NCT02359396
A Randomized, Open-label, Three-arm Study of MZRW on Tolerability, Exposure and Pharmacokinetics
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized open-label, three-arm, phase 1 clinical study. The investigators aim to investigate a Chinese Proprietary Medicine, MZRW on its tolerability, system exposure and pharmacokinetics profile.
Timeline
- Start
- 2014-11
- Primary completion
- 2015-07
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MZRW | Traditional medicine (herbal / TCM) | 5 g | Oral |
| Subject | MZRW | Traditional medicine (herbal / TCM) | 7.5 g | Oral |
| Subject | MZRW | Traditional medicine (herbal / TCM) | 10 g | Oral |